Haemonetics Corp. (HAE)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Haemonetics Corp. (HAE)
Go deeper and ask any question about HAE
Company Performance
Current Price
as of Oct 03, 2024$78.08
P/E Ratio
34.98
Market Cap
$4B
Description
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.
Metrics
Overview
- HQBoston, MA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerHAE
- Price$78.08-1.55%
Trading Information
- Market Cap$4.00B
- Float98.90%
- Average Daily Volume (1m)650,510
- Average Daily Volume (3m)582,304
- EPS$2.26
Company
- Revenue$1.33B
- Rev Growth (1yr)7.98%
- Net Income$38.37M
- Gross Margin49.62%
- EBITDA Margin21.87%
- EBITDA$73.51M
- EV$5.15B
- EV/Revenue3.86
- P/E34.98
- P/S3.02